Profound Medical Corp. (PROF) Financials

PROF Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 43.7 million 12.7 million
2023-09-30 50.4 million 11.9 million
2023-06-30 56.8 million 12.4 million
2023-03-31 61.2 million 12.5 million

PROF Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -7.2 million 907000
2023-09-30 -4.3 million 727000
2023-06-30 -5.1 million 842000
2023-03-31 -5.8 million 941000

PROF Net Income

No data available :(

PROF Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 26.1 million - 837000
2023-09-30 33.6 million - 879000
2023-06-30 39.3 million - 960000
2023-03-31 - - 997000

PROF Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 21.4 million
2023-09-30 21.4 million
2023-06-30 21.0 million
2023-03-31 20.9 million

PROF Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.1 million 3.0 million 2.9 million
2023-09-30 - 3.4 million 2.0 million 2.2 million
2023-06-30 - 3.2 million 2.1 million 2.3 million
2023-03-31 - 3.8 million 2.1 million 2.1 million

PROF Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.1 million 976256
2023-09-30 1.7 million 668000
2023-06-30 1.6 million 552000
2023-03-31 1.9 million 647000

PROF

Price: $7.36

52 week price:
7.11
15.49

Earnings Per Share: -1.35 USD

P/E Ratio: -6.25

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 115158

Market Capitalization: 196.5 million

Links: